Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Cytek Biosciences Inc (CTKB)

Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact GlobeNewswire - Mon Mar 9, 4:00PM CDT

FREMONT, Calif., March 09, 2026 (GLOBE NEWSWIRE) -- One year after opening its 8,500-square-foot Singapore facility, spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) is marking...

CTKB : 4.61 (-1.71%)
Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results  and Provides 2026 Outlook  GlobeNewswire - Thu Feb 26, 3:05PM CST

FREMONT, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Cytek ®  Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial...

CTKB : 4.61 (-1.71%)
Cytek Biosciences to participate at the TD Cowen 46th Annual Health Care Conference GlobeNewswire - Wed Feb 18, 3:05PM CST

FREMONT, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming...

CTKB : 4.61 (-1.71%)
Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 GlobeNewswire - Thu Feb 12, 3:05PM CST

FREMONT, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the fourth quarter...

CTKB : 4.61 (-1.71%)
Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results GlobeNewswire - Mon Jan 12, 4:00AM CST

FREMONT, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced preliminary, unaudited revenue results for the fourth...

CTKB : 4.61 (-1.71%)
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026 GlobeNewswire - Wed Nov 12, 2025

FREMONT, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Spectral flow cytometry leader  Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced its inclusion on TIME’s 2026 list of America’s Growth Leaders....

CTKB : 4.61 (-1.71%)
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year GlobeNewswire - Thu Nov 6, 2025

FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) announced today that its Cytek ® Muse ® Micro cell analyzer has been named Drug Discovery Solution...

CTKB : 4.61 (-1.71%)
Cytek Biosciences to Participate in Upcoming Investor Conferences GlobeNewswire - Thu Nov 6, 2025

FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following...

CTKB : 4.61 (-1.71%)
Cytek Biosciences Reports Third Quarter 2025 Financial Results GlobeNewswire - Wed Nov 5, 2025

FREMONT, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Cytek ®  Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial...

CTKB : 4.61 (-1.71%)
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry GlobeNewswire - Wed Oct 29, 2025

FREMONT, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amid the reduction of various government grant programs and global economic challenges that have tightened research funding, Cytek Biosciences, Inc....

CTKB : 4.61 (-1.71%)

Barchart Exclusives

Is Allbirds Stock a Buy, Sell, or Hold Amid Major Pivot to NewBird AI? Barchart - 10 minutes ago
With Allbirds betting big on a bold AI reinvention as NewBird AI, should investors buy the vision, sell the hype, or simply hold and watch? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.